Year-end Sale % OFF 
Abstract
Sinus tachycardia is common after zimeldine overdosage, but major changes in blood pressure, conduction defects, prolonged repolarization and arrhythmias appear to be much less of a problem than with tricyclic antidepressants. At therapeutic dosage, there is no evidence of significant impairment of myocardial contractility or conduction with zimeldine. A fall in blood pressure was reported in one study, but not in others, and postural hypotension, though it may occur, is not common. These findings suggest that the use of zimeldine may be associated with a lower risk of cardiovascular toxicity than has been found with the tricyclic antidepressants.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
